Skip to main content
. 2017 Aug 24;8(59):99649–99665. doi: 10.18632/oncotarget.20587

Figure 11. Working model for the inhibitory effects of silibinin on IL-1β-induced PI3K/AKT phosphorylation and NF-κB activation resulted in destruction of cartilage in human OA chondrocytes in vitro.

Figure 11